Category: In the News

Article: Lexington Biosciences is Set to Help Predict Cardiovascular Disease

Lexington Biosciences Inc. (CSE:LNB) (OTC:LXGTF) plans to commercialize an at-home product to better predict whether a person is at risk for cardiovascular disease Angela Harmantas | May 31, 2018 | SmallCapPower: Cardiovascular disease is leading cause of death in North America, and yet, nearly one-third of those deaths are preventable. Annually, over 1.5 million people

Read More

VIDEO: Lexington Biosciences Founder: We Have a Cardiovascular Disease Prediction Device

Lexington Biosciences, Inc.’s (CSE:LNB) Donald McInnes discusses the Company’s regulatory and commercialization efforts Lexington Biosciences Founder: We Have a Cardiovascular Disease Prediction Device In an interview with SmallCapPower, Lexington Biosciences, Inc. (CSE:LNB) Founder and Board Advisor Donald McInnes explains that Lexington’s technology helps predict cardiovascular disease, which is known as the “silent killer.” Find out more about

Read More

What’s the No. 1 killer of Americans?

Story highlight Heart disease and cancer are the top two killers of Americans (CNN)The leading causes of death remained the same from the year before: Heart disease is the No. 1 killer, followed by cancer, according to the U.S. Centers for Disease Control and Prevention, and infant mortality decreased 2.3%. But there is good news

Read More

Archives

Categories

Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News